Ad hoc

Probiodrug announces pricing of a EUR 13.5 million private placement of new shares

NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA   HALLE/SAALE, Germany, 5 November 2015 – Probiodrug AG (the “Company“) (Euronext […]
Do you like it?
Read more